Tumor-infiltrating Lymphocytes independently predict the Prognosis of triple-negative Breast Cancer

被引:0
|
作者
Krome, Susanne
机构
关键词
D O I
10.1055/a-2317-6029
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Patients with triple-negative breast cancer have a high risk of recurrence and metastasis even in early stages. Adjuvant and neoadjuvant chemotherapy reduces the probability. A high proportion of tumor-infiltrating lymphocytes (TIL) has been confirmed as a favorable biomarker in women treated with chemotherapy. The retrospective meta-analysis now shows an independent prognostic value of TIL in patients who were treated exclusively locoregionally.
引用
收藏
页数:1
相关论文
共 50 条
  • [2] Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
    Leon-Ferre, Roberto A.
    Jonas, Sarah Flora
    Salgado, Roberto
    Loi, Sherene
    de Jong, Vincent
    Carter, Jodi M.
    Nielsen, Torsten O.
    Leung, Samuel
    Riaz, Nazia
    Chia, Stephen
    Jules-Clement, Gerome
    Curigliano, Giuseppe
    Criscitiello, Carmen
    Cockenpot, Vincent
    Lambertini, Matteo
    Suman, Vera J.
    Linderholm, Barbro
    Martens, John W. M.
    van Deurzen, Carolien H. M.
    Timmermans, A. Mieke
    Shimoi, Tatsunori
    Yazaki, Shu
    Yoshida, Masayuki
    Kim, Sung-Bae
    Lee, Hee Jin
    Dieci, Maria Vittoria
    Bataillon, Guillaume
    Vincent-Salomon, Anne
    Andre, Fabrice
    Kok, Marleen
    Linn, Sabine C.
    Goetz, Matthew P.
    Michiels, Stefan
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (13): : 1135 - 1144
  • [3] Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: A Biomarker for Use Beyond Prognosis?
    Tsoutsou, Pelagia G.
    Bourhis, Jean
    Coukos, George
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (11) : 1297 - +
  • [4] Tumor-Infiltrating Lymphocytes and Response to Platinum in Triple-Negative Breast Cancer
    Tung, Nadine M.
    Winer, Eric P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) : 969 - +
  • [5] Functional mechanism on tumor-infiltrating lymphocytes in triple-negative breast cancer
    Kai, M.
    Mori, H.
    Kawaji, H.
    Kurata, K.
    Yamada, M.
    Kubo, M.
    Nakamura, M.
    [J]. BREAST, 2019, 44 : S96 - S96
  • [6] Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
    Si-Lin K.
    Kiley L.
    Kamis S.
    Iqbal J.
    Dent R.
    Sim Y.Y.
    [J]. Current Breast Cancer Reports, 2015, 7 (4) : 232 - 241
  • [7] Effect of Lipid Levels on Tumor-Infiltrating Lymphocytes and Prognosis in Patients with Triple-Negative Breast Cancer
    AiErken, NiJiati
    Shao, Nan
    Liu, Yuhong
    Shi, Huijuan
    Shi, Yawei
    Yuan, Zhongyu
    Lin, Ying
    [J]. BREAST CARE, 2023, 18 (05) : 390 - 398
  • [8] Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer
    Leon-Ferre, Roberto A.
    Polley, Mei-Yin
    Liu, Heshan
    Gilbert, Judith A.
    Cafourek, Victoria
    Hillman, David W.
    Elkhanany, Ahmed
    Akinhanmi, Margaret
    Lilyquist, Jenna
    Thomas, Abigail
    Negron, Vivian
    Boughey, Judy C.
    Liu, Minetta C.
    Ingle, James N.
    Kalari, Krishna R.
    Couch, Fergus J.
    Visscher, Daniel W.
    Goetz, Matthew P.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (01) : 89 - 99
  • [9] Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer
    Roberto A. Leon-Ferre
    Mei-Yin Polley
    Heshan Liu
    Judith A. Gilbert
    Victoria Cafourek
    David W. Hillman
    Ahmed Elkhanany
    Margaret Akinhanmi
    Jenna Lilyquist
    Abigail Thomas
    Vivian Negron
    Judy C. Boughey
    Minetta C. Liu
    James N. Ingle
    Krishna R. Kalari
    Fergus J. Couch
    Daniel W. Visscher
    Matthew P. Goetz
    [J]. Breast Cancer Research and Treatment, 2018, 167 : 89 - 99
  • [10] Tumor-infiltrating lymphocytes in triple negative breast cancer
    Zakhartseva, L. M.
    Yanovytska, M. O.
    [J]. PATHOLOGIA, 2020, (03): : 287 - 294